ReviewJournal of medical ethics2006
Potentiality of embryonic stem cells: an ethical problem even with alternative stem cell sources.
Review in Journal of medical ethics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Efficient and reliable measles reprogramming platform for the generation of human iPSC.Molecular therapy. Advances · 2026Article
- Back to the Future-A 50-Year Dive into Embryo Implantation Research: Cell Biological Paradox, Epithelial Cell Polarity, and EMT.Biomolecules · 2026Review
- Strategies of Bladder Reconstruction after Partial or Radical Cystectomy for Bladder Cancer.Molecular biotechnology · 2025Review
- Stem Cell Therapy for Diseases of Livestock Animals: An In-Depth Review.Veterinary sciences · 2025Review
- Clinical translation of human iPSC technologies: advances, safety concerns, and future directions.Frontiers in cell and developmental biology · 2025Review
- Potentiality switches and epistemic uncertainty: the Argument from Potential in times of human embryo-like structures.Medicine, health care, and philosophy · 2024Article
- Application of Orthobiologics in Achilles Tendinopathy: A Review.Life (Basel, Switzerland) · 2022Review
- Review
- The ethics of human-embryoids model: a call for consistency.Journal of molecular medicine (Berlin, Germany) · 2021Review
- Hepatogenic Potential and Liver Regeneration Effect of Human Liver-derived Mesenchymal-Like Stem Cells.Cells · 2020Article
- Plants and Their Bioactive Constituents in Mesenchymal Stem Cell-Based Periodontal Regeneration: A Novel Prospective.BioMed research international · 2018Review
- Efficient Generation of Functionally Active Spinal Cord Neurons from Spermatogonial Stem Cells.Molecular neurobiology · 2017Article
- Characterization of tubular liquid crystal structure in embryonic stem cell derived embryoid bodies.Cell & bioscience · 2017Article
- Tissue-Engineering Approaches to Restore Kidney Function.Current diabetes reports · 2015Review
- Engineering myocardial tissue patches with hierarchical structure-function.Annals of biomedical engineering · 2015Review
- What justifies the United States ban on federal funding for nonreproductive cloning?Medicine, health care, and philosophy · 2013Article
- Regenerative therapy for neuronal diseases with transplantation of somatic stem cells.World journal of stem cells · 2013Review
- Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cells.Molecular biotechnology · 2013Review
- Article
- Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury.BMC gastroenterology · 2012Article
Corrections and comments
- Erratum issued
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The recent discussions about alternative sources of human embryonic stem cells (White Paper of the US President's Council on Bioethics, 2005), while stirring new interest in the developmental potential of the various abnormal embryos or constructs proposed as such sources, also raise questions about the potential of the derived embryonic stem cells. The data on the developmental potential of embryonic stem cells that seem relevant for ethical considerations and aspects of patentability are discussed. Particular attention is paid to the meaning of "totipotency, omnipotency and pluripotency" as illustrated by a comparison of the developmental potential of three-dimensional clusters of blastomeres (morula), embryonic stem cells, somatic or (adult) stem cells or other somatic (non-stem) cells. This paper focuses on embryoid bodies and on direct cloning by tetraploid complementation. Usage and patenting of these cells cannot be considered to be ethically sound as long as totipotency and tetraploid complementability of embryonic stem cells are not excluded for the specific cell line in question. Testing this poses an ethical problem in itself and needs to be discussed in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.